Bio-Repository of DNA in Stroke: an Epidemiological and Genetic Study
NCT ID: NCT05491824
Last Updated: 2022-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
7500 participants
OBSERVATIONAL
2005-06-11
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MORbidity PRevalence Estimate In StrokE
NCT03605381
Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke
NCT05643001
RNA Sequencing Analysis in Large Vessel Occlusion Stroke DATA Bank
NCT03490552
Liverpool-Heart and BRain Project Stroke Cohort
NCT05132465
COVID-19 Stroke Apical Lung Examination Study
NCT04640428
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke
No interventions assigned to this group
Non-stroke
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of haemorrhagic or ischemic stroke using World Health Organization guidelines confirmed by clinical examination and imaging (CT or MRI).
* All patients with cerebral arteriovascular malformations and aneurysms.
* South Asian or Caucasian ethnic backgrounds.
* Patient or relative written informed consent.
* Patients should be aged \> 18 years at the time of enrolment.
* No previous history of stroke.
* able to provide written consent.
Exclusion Criteria
* Stroke not defined on CT or MRI.
Controls
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal Holloway University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pankaj Sharma, MD PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pankaj Sharma, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Royal Holloway University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Pankaj Sharma, MD PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BRAINS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.